AMP-activated protein kinase: An attractive therapeutic target for ischemia-reperfusion injury
Author:
Funder
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Pharmacology
Reference75 articles.
1. Inhibiting the inflammatory injury after myocardial ischemia reperfusion with plasma-derived alpha-1 antitrypsin: a post hoc analysis of the VCU-alpha1RT study;Abouzaki;J. Cardiovasc. Pharmacol.,2018
2. Hispidulin protects against focal cerebral ischemia reperfusion injury in rats;An;J. Mol. Neurosci. : M. Inc.,2018
3. Pre-treatment with metformin activates Nrf2 antioxidant pathways and inhibits inflammatory responses through induction of AMPK after transient global cerebral ischemia;Ashabi;Metab. Brain Dis.,2015
4. Activation of AMP-activated protein kinase by metformin protects against global cerebral ischemia in male rats: interference of AMPK/PGC-1alpha pathway;Ashabi;Metab. Brain Dis.,2014
5. Protective effects of curcumin against ischemia-reperfusion injury in the liver;Bavarsad;Pharmacol. Res.,2019
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Astragaloside IV promotes cerebral tissue restoration through activating AMPK- mediated microglia polarization in ischemic stroke rats;Journal of Ethnopharmacology;2024-11
2. Energy Metabolism and Metformin: Effects on Ischemia-Reperfusion Injury in Kidney Transplantation;Biomedicines;2024-07-10
3. Metformin attenuates lung ischemia-reperfusion injury and necroptosis through AMPK pathway in type 2 diabetic recipient rats;BMC Pulmonary Medicine;2024-05-14
4. Sophoricoside ameliorates cerebral ischemia-reperfusion injury dependent on activating AMPK;European Journal of Pharmacology;2024-05
5. Research Progress on Metformin Protection against Ischemic Reperfusion Myocardial In-jury Based on AMPK Pathway;Advances in Clinical Medicine;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3